Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species

Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species

Abstract Background Cost-effectiveness studies of echinocandins for the treatment of invasive candidiasis, including candidemia, are rare in Asia. No study has determined whether echinocandins are cost-effective for both Candida albicans and non-albicans Candida species. There have been no economic...

Full description

Bibliographic Details
Main Authors: Huang-Tz Ou, Tsung-Ying Lee, Yee-Chun Chen, Claudie Charbonneau
Format: Article
Language:English
Published: BMC 2017-07-01
Series:BMC Infectious Diseases
Subjects:
Pharmacoeconomics
Antifungal therapy
Candidemia
Anidulafungin
Echinocandin
Fluconazole
Online Access:http://link.springer.com/article/10.1186/s12879-017-2573-8

Internet

http://link.springer.com/article/10.1186/s12879-017-2573-8

Similar Items